Please provide your email address to receive an email when new articles are posted on . Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, ...

Manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) have been ordered by the Food and Drug Administration (FDA) to stop selling and ...

Manufacturers of surgical mesh products for transvaginal repair of pelvic organ prolapse have been ordered to stop selling and distributing the products in the U.S. The Food and Drug Administration ...

December 26, 2008 — Trocar-guided transvaginal mesh surgery for pelvic organ prolapse results in good clinical outcomes at 1 year, according to the results of a prospective, multicenter cohort study ...

The U.S. Food and Drug Administration today issued two final orders to manufacturers and the public to strengthen the data requirements for surgical mesh to repair pelvic organ prolapse (POP) ...

The Food and Drug Administration is ordering companies that produce mesh devices for women suffering from pelvic organ prolapse to end the sales of those products immediately. The companies, "Boston ...

This section describes safety outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see NICE ...